Randomised, double blind, multicentre, placebo controlled study of sulodexide in the treatment of venous leg ulcers.

Abstract:

:Sulodexide, a highly purified glycosaminoglycan, was investigated for treatment of venous leg ulcers. Patients (n = 235) undergoing local treatment including wound care and compression bandaging, were randomised to receive either sulodexide or matching placebo for three months. Primary study endpoint was complete ulcer healing after 2 months; secondary endpoints were ulcer healing at 3 months and the time-course changes of ulcer areas. The proportion of patients with complete ulcer healing was higher with sulodexide at 2 months (p = 0.018) and 3 months. The "number needed to treat" to obtain one additional patient healed with sulodexide was 7 at 2 months and 5 at 3 months. The changes in ulcer surface area with time were significant for sulodexide only (p = 0.004). Fibrinogen significantly decreased in sulodexide patients (p = 0.006). In conclusion, sulodexide associated with local treatment proved to be effective and well tolerated in the management of venous leg ulcers.

journal_name

Thromb Haemost

authors

Coccheri S,Scondotto G,Agnelli G,Aloisi D,Palazzini E,Zamboni V,Venous arm of the SUAVIS (Sulodexide Arterial Venous Italian Study) Group.

keywords:

subject

Has Abstract

pub_date

2002-06-01 00:00:00

pages

947-52

issue

6

eissn

0340-6245

issn

2567-689X

journal_volume

87

pub_type

临床试验,杂志文章,多中心研究,随机对照试验
  • Recombinant variants of tissue-type plasminogen activator containing amino acid substitutions in the fibronectin finger-like domain and the kringle 1 domain.

    abstract::Tissue-type plasminogen activator (t-PA) is a fibrin-specific agent which is used to treat acute myocardial infarction. Pharmacokinetically, t-PA is characterized by a rapid clearance from the circulation. In a previous study, we constructed variant forms of t-PA with genetic modifications at the fibronectin finger-li...

    journal_title:Thrombosis and haemostasis

    pub_type: 杂志文章

    doi:

    authors: Yahara H,Matsumoto K,Maruyama H,Nagaoka T,Ikenaka Y,Yajima K,Fukao H,Ueshima S,Matsuo O

    更新日期:1994-12-01 00:00:00

  • Primary prevention of coronary arterial thrombosis with the factor Xa inhibitor rTAP in a canine electrolytic injury model.

    abstract::The antithrombotic efficacies of the coagulation factor Xa inhibitor recombinant tick anticoagulant peptide (rTAP) and heparin were compared in a canine model of left circumflex (LCX) coronary artery electrolytic lesion. Intravenous infusions of saline (controls), rTAP (50 micrograms/kg/min continuous infusion) or hep...

    journal_title:Thrombosis and haemostasis

    pub_type: 杂志文章

    doi:

    authors: Lynch JJ Jr,Sitko GR,Lehman ED,Vlasuk GP

    更新日期:1995-08-01 00:00:00

  • Detection of complement-fixing antiphospholipid antibodies in association with thrombosis.

    abstract::Antiphospholipid antibody (aPL) is a hallmark of antiphospholipid syndrome (APS), characterized by thrombosis and recurrent fetal loss. We developed a novel ELISA system to detect complement-fixing ability of anticardiolipin antibody (aCL), and evaluated its clinical usefulness through studying the prevalence of the a...

    journal_title:Thrombosis and haemostasis

    pub_type: 杂志文章

    doi:

    authors: Munakata Y,Saito T,Matsuda K,Seino J,Shibata S,Sasaki T

    更新日期:2000-05-01 00:00:00

  • DDAVP reduces bleeding during continued hirudin administration in the rabbit.

    abstract::Hirudin is a potent thrombin inhibitor derived from the leech Hirudo medicinalis salivary gland which has considerable potential for therapeutic use in thrombotic disease. The major risk attendant its use is hemorrhage. This study investigates the hypothesis that the prohemostatic effects of DDAVP infusion can curtail...

    journal_title:Thrombosis and haemostasis

    pub_type: 杂志文章

    doi:

    authors: Bove CM,Casey B,Marder VJ

    更新日期:1996-03-01 00:00:00

  • Premature arterial disease associated with familial antithrombin III deficiency.

    abstract::Antithrombin III (ATIII) deficiency is one of the few known abnormalities of the coagulation system known to predispose to venous thromboembolism but its relation to arterial disease is not established. We describe two related patients with this disorder, both of whom suffered arterial thrombotic events, at an early a...

    journal_title:Thrombosis and haemostasis

    pub_type: 杂志文章

    doi:

    authors: Johnson EJ,Prentice CR,Parapia LA

    更新日期:1990-02-19 00:00:00

  • Inhibition of urokinase by complex formation with human antithrombin III in absence and presence of heparin.

    abstract::Human antithrombin III was purified from fresh human plasma by affinity chromatography on heparin-Sepharose, affinity chromatography on concanavalin A Sepharose, gel filtration on Ultrogel AcA 34, ion exchange chromatography on DEAE A-50 Sephadex and preparative agarose gel electrophoresis. The hydrolytic activity of ...

    journal_title:Thrombosis and haemostasis

    pub_type: 杂志文章

    doi:

    authors: Clemmensen I

    更新日期:1978-06-30 00:00:00

  • Elevation of serum thrombopoietin precedes thrombocytosis in Kawasaki disease.

    abstract::Kawasaki disease (KD) is an acute systemic vasculitis causing coronary arterial aneurysms and myocardial infarction in young children. Prominent thrombocytosis with increased megakaryocytes develops during the convalescent period. To clarify the mechanisms of thrombocytosis, we studied serum levels of thrombopoietin (...

    journal_title:Thrombosis and haemostasis

    pub_type: 杂志文章

    doi:

    authors: Ishiguro A,Ishikita T,Shimbo T,Matsubara K,Baba K,Hayashi Y,Naritaka S,Nakahata T

    更新日期:1998-06-01 00:00:00

  • Antibodies against fibrinogen in pregnant women, in post delivery women and in the newborns.

    abstract::Pregnancy and delivery have measurable effects on haemostatic and immunological changes. Degradation of fibrinogen induces significant structural and conformational modulation and leads to the progressive loss of antigenic sites present on the parent molecule but also exposes some new sites. These neoantigens may be r...

    journal_title:Thrombosis and haemostasis

    pub_type: 杂志文章

    doi:

    authors: Kondera-Anasz Z

    更新日期:1998-05-01 00:00:00

  • Seasonal and monthly variability in the incidence of venous thromboembolism. A systematic review and a meta-analysis of the literature.

    abstract::Many studies showed that the occurrence of cardiovascular and cerebrovascular events exhibits a seasonal and monthly variation. Evidences of a seasonal and monthly variation in the incidence of venous thromboembolism (VTE) are more conflicting. We conducted a systematic review and a meta-analysis of the literature to ...

    journal_title:Thrombosis and haemostasis

    pub_type: 杂志文章,meta分析,评审

    doi:10.1160/TH11-02-0116

    authors: Dentali F,Ageno W,Rancan E,Donati AV,Galli L,Squizzato A,Venco A,Mannucci PM,Manfredini R

    更新日期:2011-09-01 00:00:00

  • Blood coagulation kinetics: high throughput method for real-time reaction monitoring.

    abstract::A high throughput 384-well plate assay of blood function in 60 microl reactions with the fluorogenic thrombin substrate, boc-VPR-MCA, allowed for real-time monitoring of coagulation under a diverse set of reaction conditions. Using recalcified, citrated whole blood diluted 3-fold with corn trypsin inhibitor (to block ...

    journal_title:Thrombosis and haemostasis

    pub_type: 杂志文章

    doi:10.1160/TH04-03-0154

    authors: Lo K,Diamond SL

    更新日期:2004-10-01 00:00:00

  • An experimental model of intracranial hemorrhage during thrombolytic therapy with t-PA.

    abstract::Multiple clinical trials have proven that thrombolytic therapy is an effective treatment for acute myocardial infarction. Spontaneous intracranial hemorrhage (ICH) occurs in a small percentage of patients as a result of the treatment. The etiology of the ICH is unknown and there is currently no established experimenta...

    journal_title:Thrombosis and haemostasis

    pub_type: 杂志文章

    doi:

    authors: Paoni NF,Steinmetz HG,Gillett N,Refino CJ,Badillo JM,Bunting S

    更新日期:1996-05-01 00:00:00

  • Factors associated with failure to correct the international normalised ratio following fresh frozen plasma administration among patients treated for warfarin-related major bleeding. An analysis of electronic health records.

    abstract::This study assessed the frequency and factors associated with failure to correct international normalised ratio (INR) in patients administered fresh frozen plasma (FFP) for warfarin-related major bleeding. This retrospective database analysis used electronic health records from an integrated health system. Patients wh...

    journal_title:Thrombosis and haemostasis

    pub_type: 杂志文章

    doi:10.1160/TH11-09-0646

    authors: Menzin J,White LA,Friedman M,Nichols C,Menzin J,Hoesche J,Bergman GE,Jones C

    更新日期:2012-04-01 00:00:00

  • Ultra-low-molecular-weight heparins: precise structural features impacting specific anticoagulant activities.

    abstract::Ultra-low-molecular-weight heparins (ULMWHs) with better efficacy and safety ratios are under development; however, there are few structural data available. The main structural features and molecular weight of ULMWHs were studied and compared to enoxaparin. Their monosaccharide composition and average molecular weight...

    journal_title:Thrombosis and haemostasis

    pub_type: 杂志文章

    doi:10.1160/TH12-11-0795

    authors: Lima MA,Viskov C,Herman F,Gray AL,de Farias EH,Cavalheiro RP,Sassaki GL,Hoppensteadt D,Fareed J,Nader HB

    更新日期:2013-03-01 00:00:00

  • Pharmacokinetics, safety, and tolerability of edoxaban in end-stage renal disease subjects undergoing haemodialysis.

    abstract::Edoxaban is an oral, direct, once-daily, factor Xa inhibitor developed for stroke prevention in patients with atrial fibrillation and for the treatment and secondary prevention of recurrent thromboembolism in patients with acute symptomatic venous thromboembolism. Among elderly patients who require anticoagulation the...

    journal_title:Thrombosis and haemostasis

    pub_type: 杂志文章,随机对照试验

    doi:10.1160/TH14-06-0547

    authors: Parasrampuria DA,Marbury T,Matsushima N,Chen S,Wickremasingha PK,He L,Dishy V,Brown KS

    更新日期:2015-04-01 00:00:00

  • A comparison of the safety and efficacy of oral anticoagulation for the treatment of venous thromboembolic disease in patients with or without malignancy.

    abstract::The optimal long-term treatment of acute venous thromboembolism (VTE) in patients with malignancy remains undefined. In particular, based on current evidence, it is uncertain whether secondary prophylaxis using standard intensity oral anticoagulant therapy is associated with higher risks of bleeding and recurrent thro...

    journal_title:Thrombosis and haemostasis

    pub_type: 临床试验,杂志文章,多中心研究

    doi:

    authors: Palareti G,Legnani C,Lee A,Manotti C,Hirsh J,D'Angelo A,Pengo V,Moia M,Coccheri S

    更新日期:2000-11-01 00:00:00

  • The effect of glycaemic control on fibrin network structure of type 2 diabetic subjects.

    abstract::Diabetic subjects have been shown to have altered fibrin network structures. One possible cause may be fibrinogen glycation resulting in altered structure/function properties. We investigated the effect of glucose control on fibrinogen glycation and fibrin network structure in type 2 diabetes. Blood samples were taken...

    journal_title:Thrombosis and haemostasis

    pub_type: 杂志文章

    doi:

    authors: Pieters M,Covic N,Loots du T,van der Westhuizen FH,van Zyl DG,Rheeder P,Jerling JC,Weisel JW

    更新日期:2006-11-01 00:00:00

  • ADP-mimicking platelet aggregation caused by rugosin E, an ellagitannin isolated from Rosa rugosa Thunb.

    abstract::Among the nine ellagitannins, rugosin E was the most potent platelet aggregating agent with an EC50 of 1.5 +/- 0.1 microM in rabbit platelets and 3.2 +/- 0.1 microM in human platelets. The aggregations caused by rugosin E and ADP were inhibited by EGTA, PGE1, mepacrine, sodium nitroprusside and neomycin, but not by in...

    journal_title:Thrombosis and haemostasis

    pub_type: 杂志文章

    doi:

    authors: Teng CM,Kang YF,Chang YL,Ko FN,Yang SC,Hsu FL

    更新日期:1997-03-01 00:00:00

  • Selective activation of the prostaglandin E2 receptor subtype EP2 or EP4 leads to inhibition of platelet aggregation.

    abstract::The effect of selective activation of platelet prostaglandin (PG) E2 receptor subtype EP2 or EP4 on platelet aggregation remains to be determined. In platelets prepared from wild-type mice (WT platelets), high concentrations of PGE2 inhibited platelet aggregation induced by U-46619, a thromboxane receptor agonist. How...

    journal_title:Thrombosis and haemostasis

    pub_type: 杂志文章

    doi:10.1160/TH10-01-0043

    authors: Kuriyama S,Kashiwagi H,Yuhki K,Kojima F,Yamada T,Fujino T,Hara A,Takayama K,Maruyama T,Yoshida A,Narumiya S,Ushikubi F

    更新日期:2010-10-01 00:00:00

  • Long-term bleeding risk prediction in 'real world' patients with atrial fibrillation: Comparison of the HAS-BLED and ABC-Bleeding risk scores. The Murcia Atrial Fibrillation Project.

    abstract::Risk scores in patients with atrial fibrillation (AF) based on clinical factors alone generally have only modest predictive value for predicting high risk patients that sustain events. Biomarkers might be an attractive prognostic tool to improve bleeding risk prediction. The new ABC-Bleeding score performed better tha...

    journal_title:Thrombosis and haemostasis

    pub_type: 杂志文章

    doi:10.1160/TH17-07-0478

    authors: Esteve-Pastor MA,Rivera-Caravaca JM,Roldan V,Vicente V,Valdés M,Marín F,Lip GYH

    更新日期:2017-10-05 00:00:00

  • Precise carrier diagnosis in families with haemophilia A: use of conformation sensitive gel electrophoresis for mutation screening and polymorphism analysis.

    abstract::Causative mutations in the factor VIII gene of seven unrelated patients with severe haemophilia A were identified using the mutation screening procedure conformation sensitive gel electrophoresis (1) and characterised by direct sequencing. Female family members of all patients had requested either carrier status deter...

    journal_title:Thrombosis and haemostasis

    pub_type: 杂志文章

    doi:

    authors: Williams IJ,Abuzenadah A,Winship PR,Preston FE,Dolan G,Wright J,Peake IR,Goodeve AC

    更新日期:1998-04-01 00:00:00

  • A multicentre randomised assessment of the DAWN AC computer-assisted oral anticoagulant dosage program.

    abstract::Computer-assisted oral anticoagulant dosage is being increasingly used to meet growing demands for oral anticoagulation. The DAWN AC is one of the most widely used computer-dosage programs. Evidence of its value and that of other computer programs has been based previously only on laboratory evidence of "time in targe...

    journal_title:Thrombosis and haemostasis

    pub_type: 杂志文章,多中心研究,随机对照试验

    doi:

    authors: Poller L,Keown M,Ibrahim S,Lowe G,Moia M,Turpie AG,Roberts C,van den Besselaar AM,van der Meer FJ,Tripodi A,Palareti G,Shiach C,Bryan S,Samama M,Burgess-Wilson M,Heagerty A,Maccallum P,Wright D,Jespersen J,European

    更新日期:2009-03-01 00:00:00

  • Heparin from bovine intestinal mucosa: glycans with multiple sulfation patterns and anticoagulant effects.

    abstract::Pharmaceutical grade heparins from porcine intestine and bovine lung consist mainly of repeating tri-sulfated units, of the disaccharide →4-α-IdoA2S-1→4-α-GlcNS6S-1→. Heparin preparations from bovine intestine, in contrast, are more heterogeneous. Nuclear magnetic resonance (NMR) and disaccharide analysis after hepari...

    journal_title:Thrombosis and haemostasis

    pub_type: 杂志文章

    doi:10.1160/TH-11-07-0518

    authors: Tovar AM,Capillé NV,Santos GR,Vairo BC,Oliveira SN,Fonseca RJ,Mourão PA

    更新日期:2012-05-01 00:00:00

  • A comparative multi-laboratory assessment of three factor VIII/von Willebrand factor concentrates.

    abstract::Five expert laboratories have participated in a cross-laboratory study to co-evaluate and compare three commercial Factor VIII/von Willebrand factor (VWF) concentrates. A total of nine factor concentrate lots were evaluated, comprising AHF (High Purity) (AHF HP; x3), Biostate (x3) and Humate/Haemate (x3). All laborato...

    journal_title:Thrombosis and haemostasis

    pub_type: 杂志文章

    doi:

    authors: Favaloro EJ,Bukuya M,Martinelli T,Tzouroutis J,Duncan E,Welldon K,Collecutt M,Aumann H,Thom J,Gilmore G

    更新日期:2002-03-01 00:00:00

  • Antithrombin cambridge II (Ala384Ser): clinical, functional and haplotype analysis of 18 families.

    abstract::Thirty-one individuals from 18 unrelated families with antithrombin deficiency have been identified as having a single point mutation within codon 384 (13268 GCA-->TCA) resulting in an alanine to serine substitution. Six families (11 individuals) were identified by the screening of individuals with thromboembolic dise...

    journal_title:Thrombosis and haemostasis

    pub_type: 杂志文章

    doi:

    authors: Perry DJ,Daly ME,Tait RC,Walker ID,Brown K,Beauchamp NJ,Preston FE,Gyde H,Harper PL,Carrell RW

    更新日期:1998-02-01 00:00:00

  • Influence of some plasma fatty acids on the phospholipid fatty acid pattern of human platelets--an "ex vivo" experience.

    abstract::Some correlations between plasma and platelet fatty acids (FA) were evaluated "ex vivo" in 94 normal subjects. The highest relationships between total FA from plasma and platelets were found for 18:1 (r = 0.74) and 18:2 (r = 0.67). Low correlations were obtained for free fatty acids (FFA). The most significant correla...

    journal_title:Thrombosis and haemostasis

    pub_type: 杂志文章

    doi:

    authors: Vallés J,Aznar J,Santos MT

    更新日期:1984-12-29 00:00:00

  • Tick saliva is a potent inhibitor of endothelial cell proliferation and angiogenesis.

    abstract::We report for the first time that saliva of the hard tick and Lyme disease vector, Ixodes scapularis, is a potent inhibitor of angiogenesis. Saliva (< or = 1:500 dilutions) or salivary gland (0.1-0.5 pairs/assay) dose-dependently inhibits microvascular endothelial cell (MVEC) proliferation. Inhibition was also detecte...

    journal_title:Thrombosis and haemostasis

    pub_type: 杂志文章

    doi:10.1160/TH04-09-0566

    authors: Francischetti IM,Mather TN,Ribeiro JM

    更新日期:2005-07-01 00:00:00

  • A novel inhibitor of activated thrombin-activatable fibrinolysis inhibitor (TAFIa) - part I: pharmacological characterization.

    abstract::We have discovered a novel small-molecule (3-phosphinoylpropionic acid) inhibitor of activated thrombin activatable fibrinolysis inhibitor (TAFIa), BX 528, which had an IC (50) of 2 nM in an enzymatic assay and 50 nM in an in-vitro clot lysis assay, with 3,500- to 35,000-fold selectivity against other carboxypeptidase...

    journal_title:Thrombosis and haemostasis

    pub_type: 杂志文章

    doi:

    authors: Wang YX,Zhao L,Nagashima M,Vincelette J,Sukovich D,Li W,Subramanyam B,Yuan S,Emayan K,Islam I,Hrvatin P,Bryant J,Light DR,Vergona R,Morser J,Buckman BO

    更新日期:2007-01-01 00:00:00

  • Identification of three novel plasminogen (PLG) gene mutations in a series of 23 patients with low PLG activity.

    abstract::Inherited severe hypoplasminogenaemia is a multisystemic disorder leading to deficient extravascular fibrinolysis. As a clinical consequence wound healing capacity of mucous membranes is markedly impaired leading to ligneous conjunctivitis and several other manifestations. Here we report the molecular genetic and clin...

    journal_title:Thrombosis and haemostasis

    pub_type: 杂志文章

    doi:10.1160/TH10-04-0216

    authors: Klammt J,Kobelt L,Aktas D,Durak I,Gokbuget A,Hughes Q,Irkec M,Kurtulus I,Lapi E,Mechoulam H,Mendoza-Londono R,Palumbo JS,Steitzer H,Tabbara KF,Ozbek Z,Pucci N,Sotomayor T,Sturm M,Drogies T,Ziegler M,Schuster V

    更新日期:2011-03-01 00:00:00

  • Effects of low intensity antithrombotic regimes on the haemoglobin level.

    abstract::The effects on the haemoglobin level of low dose aspirin and of low intensity oral anticoagulation with warfarin separately and in combination have been established in men aged between 45 and 69 at high risk of ischaemic heart disease. The findings confirm that combined treatment with warfarin and aspirin (WA) leads t...

    journal_title:Thrombosis and haemostasis

    pub_type: 临床试验,杂志文章

    doi:

    authors: Meade TW,Howarth DJ,Brennan PJ

    更新日期:1994-03-01 00:00:00

  • Evidence that adenosine diphosphate can activate adenylate cyclase via conversion to adenosine in platelet-rich plasma containing magnesium.

    abstract::When adenosine diphosphate (ADP) is added to hirudinized platelet-rich plasma (PRP) in which the level of platelet cAMP has been pharmacologically elevated, there is an initial rapid fall in the level of cAMP brought about by inhibition of adenylate cyclase. This may be followed by a subsequent activation of adenylate...

    journal_title:Thrombosis and haemostasis

    pub_type: 杂志文章

    doi:

    authors: Glenn JR,Heptinstall S

    更新日期:1998-08-01 00:00:00